SCHEMBL7038001

SCHEMBL7038001

CCCc1c(OCc2ccccc2)ccc2c(CC)nsc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 2/20 0.38
▸ AOC3 Q16853 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ GAA P10253 2/20 0.36
▸ HTR1A P08908 1/20 0.35
▸ DRD2 P14416 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ PDE3B Q13370 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ PDE5A O76074 1/20 0.35
▸ LIPE Q05469 1/20 0.35
▸ CYSLTR2 Q9NS75 1/20 0.34
▸ CYSLTR1 Q9Y271 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27656755 0.70 KDM4E (0.46) MAPK14AOC3MAPTMAPK1TDP1
SCHEMBL7041646 0.69 PPARA (0.53) —
SCHEMBL4120541 0.69 TSHR (0.49) MAPTMAPK1TDP1L3MBTL1GAA
SCHEMBL7038827 0.68 PPARA (0.46) —
SCHEMBL9118750 0.67 MAOB (0.47) MAPK14GAAPDE5A
SCHEMBL11443590 0.66 MAPK14 (0.39) MAPK14MAPTMAPK1TDP1L3MBTL1
SCHEMBL8192704 0.65 LTA4H (0.57) MAPK14MAPTMAPK1TDP1L3MBTL1
SCHEMBL10812819 0.65 PDE5A (0.41) MAPTPDE5AKDM4EALDH1A1HPGD
SCHEMBL19705426 0.65 CTSD (0.46) MAPK14MAPTTDP1L3MBTL1GAA
SCHEMBL7046356 0.65 MAPT (0.41) MAPK14MAPTMAPK1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 — — EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 — — US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 — — EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 — — WO disclosed
Send feedback